Bayer Aktiengesellschaft (ETR:BAYN) Trading Up 1.8% – Still a Buy?

Bayer Aktiengesellschaft (ETR:BAYN)’s stock price was up 1.8% during mid-day trading on Thursday . The company traded as high as €34.77 and last traded at €34.70. Approximately 3,013,207 shares were traded during trading, The stock had previously closed at €34.10.

Bayer Aktiengesellschaft Stock Up 1.8%

The company has a current ratio of 1.06, a quick ratio of 0.72 and a debt-to-equity ratio of 134.81. The stock has a 50-day simple moving average of €38.57 and a 200-day simple moving average of €38.71. The company has a market cap of $35.03 billion, a price-to-earnings ratio of -39.81, a price-to-earnings-growth ratio of 36.39 and a beta of 0.84.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health.